Inflammatory markers as outcome predictors of COVID-19 in pregnant women.
作者信息
Fiorini Ana Claudia, Almeida Antonio-Carlos Giomaraes de, Scorza Fulvio Alexandre, Finsterer Josef
机构信息
Pontifícia Universidade Católica de São Paulo, Programa de Estudos Pós-Graduado em Fonoaudiologia - São Paulo (SP), Brazil.
Universidade Federal de São Paulo, Escola Paulista de Medicina, Departamento de Fonoaudiologia - São Paulo (SP), Brazil.
出版信息
Rev Assoc Med Bras (1992). 2023 Sep 25;69(10):e20230870. doi: 10.1590/1806-9282.20230870. eCollection 2023.
Abstract
摘要
相似文献
1
Inflammatory markers as outcome predictors of COVID-19 in pregnant women.
Rev Assoc Med Bras (1992). 2023 Sep 25;69(10):e20230870. doi: 10.1590/1806-9282.20230870. eCollection 2023.
2
Repeat positive severe acute respiratory syndrome coronavirus 2 (coronavirus disease 2019) testing ≥90 days apart in pregnant women.
Am J Obstet Gynecol MFM. 2021 May;3(3):100331. doi: 10.1016/j.ajogmf.2021.100331. Epub 2021 Feb 19.
3
An internally validated prediction model for critical COVID-19 infection and intensive care unit admission in symptomatic pregnant women.
Am J Obstet Gynecol. 2022 Mar;226(3):403.e1-403.e13. doi: 10.1016/j.ajog.2021.09.024. Epub 2021 Sep 25.
4
A systematic review of pregnant women with COVID-19 and their neonates.
Arch Gynecol Obstet. 2021 Jul;304(1):5-38. doi: 10.1007/s00404-021-06049-z. Epub 2021 Apr 2.
5
Maternal and Neonatal Outcomes in Pregnant Women With Coronavirus Disease 2019 in Korea.
J Korean Med Sci. 2022 Oct 24;37(41):e297. doi: 10.3346/jkms.2022.37.e297.
6
COVID-19 infected pregnant women and cardiotocographic features.
J Perinat Med. 2021 Dec 9;50(2):230. doi: 10.1515/jpm-2021-0422. Print 2022 Feb 23.
7
Sickle cell disease and COVID-19 in pregnant women.
J Gynecol Obstet Hum Reprod. 2022 Mar;51(3):102328. doi: 10.1016/j.jogoh.2022.102328. Epub 2022 Jan 29.
8
Asymptomatic coronavirus infection among pregnant women: a necessity for universal screening of COVID-19 in pregnant women admitted to labor.
J Matern Fetal Neonatal Med. 2022 Sep;35(18):3514-3515. doi: 10.1080/14767058.2020.1832073. Epub 2020 Oct 7.
9
Predictors of severe and critical disease in pregnant women with SARS-CoV-2.
J Matern Fetal Neonatal Med. 2022 Dec;35(25):7536-7540. doi: 10.1080/14767058.2021.1951216. Epub 2021 Sep 1.
10
Risk factors for severe and critical Covid-19 in pregnant women in a single center in Brazil.
J Matern Fetal Neonatal Med. 2022 Dec;35(25):5389-5392. doi: 10.1080/14767058.2021.1880561. Epub 2021 Feb 3.
本文引用的文献
1
Novel Hematological Biomarker Adopted for Early Sepsis Detection Emerges as Predictor of Severity for COVID Infection.
Mo Med. 2023 May-Jun;120(3):196-200.
2
Bacterial and fungal superinfections are detected at higher frequency in critically ill patients affected by SARS CoV-2 infection than negative patients and are associated to a worse outcome.
J Med Virol. 2023 Jul;95(7):e28892. doi: 10.1002/jmv.28892.
3
Correlation of systemic inflammation biomarkers and disease severity in pregnant women with COVID-19.
Rev Assoc Med Bras (1992). 2023 Jun 26;69(6):e20221614. doi: 10.1590/1806-9282.20221614. eCollection 2023.
4
Extrapulmonary onset manifestations of COVID-19.
Clinics (Sao Paulo). 2021 Jul 5;76:e2900. doi: 10.6061/clinics/2021/e2900. eCollection 2021.
5
The unique immunological and microbial aspects of pregnancy.
Nat Rev Immunol. 2017 Aug;17(8):469-482. doi: 10.1038/nri.2017.64. Epub 2017 Jun 19.
Zotero 插件